MedCity Update – September 2014
View this email in your browser

Welcome

From Dr Eliot Forster, Executive Chair of MedCity

Although August is generally held to be a quite news month, I’ve spotted a series of unrelated reports that all point to a real sense of optimism in the life sciences sector – from the fund manager who is buying pharma shares for the first time in 11 years to the Cambridge biotech entrepreneur who says that investor interest is at a 10 year high.

It all adds up to this being a great time to be a life sciences entrepreneur, and MedCity is now partnering with the OBR on the OneStart programme to encourage more young people to take their ideas to market. More details are below, and I hope that our friends in universities in particular will help us spread the word about this exciting opportunitiy.

Creating companies

MedCity partners with the Oxbridge Biotech Roundtable on OneStart, a business accelerator programme and business plan competition for life sciences entrereneurs under 35.
Read more here

“A truly enabling investment”

Last year’s OneStart winner on how the programme brought his diagnostic device for anaemia a step closer to market.

Read more

Life science investment powers London’s 2014 growth

Investment by Japan and Indian pharma makes life sciences the capital’s second biggest sector for overseas growth.
Read more

Imperial unveils Research and Translation Hub

Construction begins on Imperial College London’s flagship Research and Translation Hub – a £200m 48,000 square metre space for industry, start-ups and researchers to collaborate. The Hub wil be the centrepiece of the new Imperial West innovation district.

Read more
See the Imperial West video here

Spin-out spotlight

Cambridge spin-out JustMilk starts user acceptability trials for cheap and simple device to deliver medicines and nutrients to babies while they feed. 

Read more

New KCL Principal arrives

Professor Edward Byrne, new Principal and President of King’s College London and Chair of the King’s Health Partners Board, officially takes up his role this month. Professor Byrne, a neuroscientist and clinician by background, joins King’s from Monash University, Australia.
Read more

Cambridge Enterprise role for outgoing Imperial head

Outgoing President & Rector of Imperial College London Sir Keith O’Nions is named as the new Chair of Cambridge Enterprise, the commercialisation arm of the University of Cambridge.
Read more

Coming up

Digital Enterprise Clinic, Innovate UK
Targeting the human kinome: cancer drug discovery, The Royal Society
Modelling the molecules of life – 2014 Sir Ernst Chain Lecture, Imperial College London
Network Meeting Cambridge: Lessons from the Life Science Report 2014, OneNucleus

Healthcare innovation and regulatory decision-making in the biocentury, BIA
OBN BioTuesday: Bioentrepreneurs Panel, OBN

Email us to share your event

MedCity was established in April 2014 by the Mayor of London with the capital’s three Academic Health Science Centres – Imperial College Academic Health Centre, King’s Health Partners and UCL Partners.

The next edition of MedCity Update will be sent in the first week of October

LinkedIn
LinkedIn

Twitter
Twitter

Website
Website

Copyright © 2014 MedCity. All rights reserved.